Abstract
Gliosarcoma (GS) is a glioblastoma with a sarcomatous component that is presumed to be a metaplastic differentiation of glioma cells. We studied the clinical relevance of this histological glioblastoma subentity within the pediatric population. We obtained patient data from the German HIT-GBM database, which contains clinical data for more than 600 pediatric patients with centrally reviewed high-grade gliomas. By applying defined inclusion criteria (diagnosis of GS proven by central neuropathological review; patient age 0 to 21 years), four patients were identified. In addition, after a review of the English medical scientific literature, 19 additional cases were found. The relative frequency of GS in the German HIT-GBM database was only 1.9%. In the whole series of 23 pediatric GS patients, including previously reported cases, the male-to-female-ratio was 1.2:1. GS was found in all pediatric age groups with a median age of 11 years, but there was an unexpectedly high accumulation in infants (6 of 23 <3 years of age, 26%). GS showed a strong predilection of the cerebral hemispheres (22 out of 23 cases). Increased intracranial pressure was the leading symptom of a short clinical history with a median duration of 0.7 month. Interestingly, six patients (26%) were reported with a history of cranial radiotherapy prior to GS diagnosis. In 60% of the GS patients in our series, gross total resection was achieved. Median overall (OS) and event-free survivals (EFS) of the total cohort were 12.1 and 9.8 months, respectively. In conclusion, GS is a very rare tumor entity in children. Literature review suggests a relatively higher incidence in infants and in patients with a previous history of radiotherapy.
Similar content being viewed by others
References
Ohgaki H, Biernat W, Reis R, Hegi M, Kleihues P (2000) Gliosarcoma. In: Kleihues P, Cavenee WK (eds) Pathology and genetics of tumours of the nervous system. IARC Press, Lyon, pp 42–44
Kleihues P, Burger PC, Aldape KD (2007) Glioblastoma. In: Louis DN, Ohgaki H, Wiestler O, Cavenee WK (eds) WHO classification of tumors of the central nervous system. IARC Press, Lyon, pp 33–49
Kleihues P, Sobin LH (2000) World Health Organization classification of tumors. Cancer 88:2887
Miller CR, Perry A (2007) Glioblastoma. Arch Pathol Lab Med 131:397–406
Reis RM, Konu-Lebleblicioglu D, Lopes JM, Kleihues P, Ohgaki H (2000) Genetic profile of gliosarcomas. Am J Pathol 156:425–432
Kozak KR, Mahadevan A, Moody JS (2009) Adult gliosarcoma: epidemiology, natural history and factors associated with outcome. Neurooncology 11(2):183–191
Sarkar C, Sharma MC, Sudha K, Gaikwad S, Varma A (1997) A clinico-pathological study of 29 cases of gliosarcoma with special reference to two unique variants. Indian J Med Res 106:229–235
Lutterbach J, Guttenberger R, Pagenstecher A (2001) Gliosarcoma: a clinical study. Radiother Oncol 61:57–64
Salvati M, Lenzi J, Brogna C, Frati A, Piccirilli M, Giangaspero F, Raco A (2006) Childhood’s gliosarcomas: pathological and therapeutical considerations on three cases and critical review of the literature. Childs Nerv Syst 22:1301–1306
Radkowski MA, Naidich TP, Tomita T, Byrd SE, McLone DG (1988) Neonatal brain tumors: CT and MR findings. J Comput Assist Tomogr 12:10–20
Ono N, Nakamura M, Inoue HK, Tamura M, Murata M (1990) Congenital gliosarcoma; so-called sarcoglioma. Childs Nerv Syst 6:416–420
Okami N, Kawamata T, Kubo O, Yamane F, Kawamura H, Hori T (2002) Infantile gliosarcoma: a case and a review of the literature. Childs Nerv Syst 18:351–355
Malde R, Jalali R, Muzumdar D, Shet T, Kurkure P (2004) Gliosarcoma occurring 8 years after treatment for a medulloblastoma. Childs Nerv Syst 20:243–246
Kaschten B, Flandroy P, Reznik M, Hainaut H, Stevenaert A (1995) Radiation-induced gliosarcoma. Case report and review of the literature. J Neurosurg 83:154–162
Cerame MA, Guthikonda M, Kohli CM (1985) Extraneural metastases in gliosarcoma: a case report and review of the literature. Neurosurgery 17:413–418
Rizk T, Nabbout R, Koussa S, Akatcherian C (2000) Congenital brain tumor in a neonate conceived by in vitro fertilization. Childs Nerv Syst 16:501–502
Lach M, Wallace CJ, Krcek J, Curry B (1996) Radiation-associated gliosarcoma. Can Assoc Radiol J 47:209–212
Lee YY, Castillo M, Nauert C, Moser RP (1985) Computed tomography of gliosarcoma. AJNR Am J Neuroradiol 6:527–531
Deb P, Sharma MC, Chander B, Mahapatra AK, Sarkar C (2006) Giant cell glioblastoma multiforme: report of a case with prolonged survival and transformation to gliosarcoma. Childs Nerv Syst 22:314–319
Takaue Y, Sullivan MP, Ramirez I, Cleary KR, van Eys J (1986) Second malignant neoplasm in treated Hodgkin’s disease. Report of a patient and scope of the problem. Am J Dis Child 140:49–51
Chadduck WM, Gollin SM, Gray BA, Norris JS, Araoz CA, Tryka AF (1987) Gliosarcoma with chromosome abnormalities in a neonate exposed to heptachlor. Neurosurgery 21:557–559
Goldstein SJ, Young B, Markesberry WR (1981) Congenital malignant gliosarcoma. AJNR Am J Neuroradiol 2:475–476
Kepes JJ, Bastian FO, Weber ED (1996) Gliosarcoma developing from an irradiated ependymoma. Acta Neuropathol (Berl) 92:515–519
McKeever PE, Wichman A, Chronwall B, Thomas C, Howard R (1984) Sarcoma arising from a gliosarcoma. South Med J 77:1027–1032
Wagner S, Leuthold U, Schmid H-J, Wolff JE (2003) Pilotstudie mit hochdosiertem Methotrexat und nachfolgender simultaner Radiochemotherapie bei neun Kindern mit hochgradig-malignen Gliomen (abstract). Monatschr Kinderheilkd 151:467–476
Wagner S, Reinert C, Schmid HJ, Liebeskind AK, Jorch N, Langler A, Graf N, Warmuth-Metz M, Pietsch T, Peters O, Wolff JE (2005) High-dose methotrexate prior to simultaneous radiochemotherapy in children with malignant high-grade gliomas. Anticancer Res 25:2583–2587
Rutkowski S, Bode U, Deinlein F, Ottensmeier H, Warmuth-Metz M, Soerensen N, Graf N, Emser A, Pietsch T, Wolff JE, Kortmann RD, Kuehl J (2005) Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 352:978–986
Morantz RA, Feigin I, Ransohoff J 3rd (1976) Clinical and pathological study of 24 cases of gliosarcoma. J Neurosurg 45:398–408
Kramm CM, Wagner S, Van Gool S, Schmid H, Strater R, Gnekow A, Rutkowski S, Wolff JE (2006) Improved survival after gross total resection of malignant gliomas in pediatric patients from the HIT-GBM studies. Anticancer Res 26:3773–3779
Heideman RL, Kuttesch J Jr, Gajjar AJ, Walter AW, Jenkins JJ, Li Y, Sanford RA, Kun LE (1997) Supratentorial malignant gliomas in childhood: a single institution perspective. Cancer 80:497–504
Artico M, Cervoni L, Celli P, Salvati M, Palma L (1993) Supratentorial glioblastoma in children: a series of 27 surgically treated cases. Childs Nerv Syst 9:7–9
Holt LE (1917) Gliosarcoma in an infant of seven weeks, resembling hydrocephalus. Am J Dis Child 14:219–221
Duffner PK, Horowitz ME, Krischer JP, Friedman HS, Burger PC, Cohen ME, Sanford RA, Mulhern RK, James HE, Freeman CR et al (1993) Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 328:1725–1731
Dufour C, Grill J, Lellouch-Tubiana A, Puget S, Chastagner P, Frappaz D, Doz F, Pichon F, Plantaz D, Gentet JC, Raquin MA, Kalifa C (2006) High-grade glioma in children under 5 years of age: a chemotherapy only approach with the BBSFOP protocol. Eur J Cancer 42:2939–2945
Geyer JR, Finlay JL, Boyett JM, Wisoff J, Yates A, Mao L, Packer RJ (1995) Survival of infants with malignant astrocytomas. A Report from the Childrens Cancer Group. Cancer 75:1045–1050
Wagner S, Rutkowski S, Reinert C, Straeter R, Slavc I, Pietsch T, Van Gool S, Wolff JE (2006) High grade gliomas in infants and very young children: a retrospective analysis of 30 patients (abstract). Pediatr Blood Cancer 47:356–532
Perry JR, Ang LC, Bilbao JM, Muller PJ (1995) Clinicopathologic features of primary and postirradiation cerebral gliosarcoma. Cancer 75:2910–2918
Acknowledgments
The ongoing support of the Deutsche Kinderkrebsstiftung, Bonn, Germany, is greatly acknowledged. Without this support performance of clinical trials as well as quality control measures like central neuropathological and neuroradiological review and a central review of radiotherapy planning would not be possible within the HIT network. We also thank all colleagues who contributed patients and their data to the HIT-GBM studies.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Karremann, M., Rausche, U., Fleischhack, G. et al. Clinical and epidemiological characteristics of pediatric gliosarcomas. J Neurooncol 97, 257–265 (2010). https://doi.org/10.1007/s11060-009-0021-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-009-0021-3